SCHEMBL10069050

SCHEMBL10069050

COCCOc1cc(C(=O)OC)cc(C(OCCNC(=O)OC)c2cccc(F)c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.40
RPS6KB1 P23443 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.37
REN P00797 3/20 0.37
HTR1A P08908 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
SLC6A9 P48067 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35
BRD4 O60885 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
RECQL P46063 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068802 0.89 KLKB1 (0.41) MEN1LMNAKMT2AALDH1A1REN
SCHEMBL10068953 0.84 KLKB1 (0.40) MEN1LMNAKMT2AALDH1A1REN
SCHEMBL10068784 0.81 MEN1 (0.39) MEN1LMNAKMT2AALDH1A1REN
SCHEMBL10069048 0.81 MRGPRX4 (0.44) AURKARPS6KB1MRGPRX4MEN1LMNA
SCHEMBL10068771 0.81 FAAH (0.43) MEN1LMNAKMT2AALDH1A1MAPK1
SCHEMBL10068722 0.80 HTT (0.40) MEN1LMNAKMT2ARENBRD4
SCHEMBL10069049 0.80 MRGPRX4 (0.40) AURKARPS6KB1MRGPRX4MEN1LMNA
SCHEMBL10069369 0.79 KDM4E (0.44) MEN1LMNAKMT2AALDH1A1REN
SCHEMBL10068545 0.79 ADRB2 (0.37) MRGPRX4MEN1LMNAKMT2AREN
SCHEMBL3341708 0.79 ADRB2 (0.41) MRGPRX4MEN1LMNAKMT2AREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019428-A1 BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed